無排卵(Anovulation):治療薬開発パイプライン動向2015

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DELVP501048)
◆英語タイトル:Anovulation-Pipeline Insights, 2015
◆発行会社/調査会社:DelveInsight
◆商品コード:DELVP501048
◆発行日:2015年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:60以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(納品まで約3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD1,250 ⇒換算¥137,500見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[無排卵(Anovulation):治療薬開発パイプライン動向2015]についてメールでお問い合わせはこちら
本調査レポートでは、世界における無排卵(Anovulation)の治療薬開発パイプライン動向について調査・分析し、企業別開発中の治療薬、各臨床試験段階における製品リスト及び比較分析、薬剤候補のプロファイル、治療薬の評価、開発中止又は開発休止中の製品リスト等をお届けしています。また、無排卵(Anovulation)治療薬開発に取り組んでいる企業情報も提供しています。(※本レポートはご注文を頂いてから、最新データに更新して納品しているため、正確なページ数を明記しておりません。)

・無排卵(Anovulation)の概要

・無排卵(Anovulation)のパイプライン製品概要

・企業別開発中の治療薬

・後期治験段階の製品(Filed & Phase III):比較分析

・中期治験段階の製品(Phase II):比較分析

・初期治験段階の製品(Phase I & IND):比較分析

・前臨床段階の製品:比較分析

・薬剤候補のプロファイル

・無排卵(Anovulation)治療薬の評価
  - 単剤治療薬
  - 併用治療薬
  - 投与経路別
  - 分子の種類別

・開発が中止された製品リスト

・開発休止中の製品リスト

・無排卵(Anovulation)治療薬開発に取り組んでいる企業リスト

・図表一覧
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s,“ Anovulation-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Anovulation. This report provides information on the therapeutic development based on the Anovulation dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

[Data Sources]

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.


Scope
• The report provides a snapshot of the global therapeutic landscape of Anovulation
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Anovulation pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Anovulation and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


*** レポート目次(コンテンツ)***

Table of Contents
• Anovulation Overview
• Anovulation Pipeline Therapeutics
• Anovulation Therapeutics under Development by Companies
• Anovulation Late Stage Products (Filed and Phase III)
– Comparative Analysis
• Anovulation Mid Clinical Stage Products (Phase II)
– Comparative Analysis
• Anovulation Early Clinical Stage Products (Phase I and IND Filed)
– Comparative Analysis
• Anovulation Discovery and Pre-Clinical Stage Products
– Comparative Analysis
• Drug Candidate Profiles
• Anovulation – Therapeutics Assessment
– Assessment by Monotherapy Products
– Assessment by Combination Products
– Assessment by Route of Administration
– Assessment by Molecule Type
• Anovulation – Discontinued Products
• Anovulation – Dormant Products
• Companies Involved in Therapeutics Development for Anovulation
• Appendix
• Methodology
• Contact Us
• Disclaimer

List of Tables
• Number of Products under Development for Anovulation, 2015
• Number of Products under Development by Companies
• Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2015
• Comparative Analysis Mid Clinical Stage Products (Phase II), 2015
• Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2015
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2015
• Drug Candidates Profiles
• Anovulation Assessment by Monotherapy Products
• Anovulation Assessment by Combination Products
• Anovulation Assessment by Route of Administration
• Anovulation Assessment by Stage and Route of Administration
• Anovulation Assessment by Molecule Type
• Anovulation Assessment by Stage and Molecule Type
• Anovulation Therapeutics – Discontinued Products
• Anovulation Therapeutics – Dormant Products
• Products under Development by Companies, 2015


List of Figures
• Number of Products under Development for Anovulation, 2015
• Late Clinical Stage Products (Filed and Phase III), 2015
• Mid Clinical Stage Products (Phase II), 2015
• Early Clinical Stage Products (Phase I and IND Filed), 2015
• Discovery and Pre-Clinical Stage Products, 2015
• Anovulation Assessment by Monotherapy Products
• Anovulation Assessment by Combination Products
• Anovulation Assessment by Route of Administration
• Anovulation Assessment by Stage and Route of Administration
• Anovulation Assessment by Molecule Type
• Anovulation Assessment by Stage and Molecule Type


*** レポートのキーワード ***

無排卵(Anovulation)、治療薬(医薬品、薬剤)、製薬企業、研究開発、治験、製品パイプライン

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 世界の肝臓移植市場2016
    2016 Global Liver Transplantation Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Liver Transplantation industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan …
  • サウジアラビアの硫黄華市場2015
    The report presents analysis of sublimed sulphur market in Saudi Arabia. [Scope] Brief country profile includes general information and main economic indicators and specifies business environment in Saudi Arabia Sublimed Sulphur market is analyzed by different parameters including domestic productio …
  • 世界の結核検査市場2017
    Tuberculosis Testing Market Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United St …
  • フリードライヒ運動失調症(Friedreich Ataxia):治療薬開発パイプライン動向(2014年下半期版)
    Friedreich Ataxia - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Friedreich Ataxia - Pipeline Review, H2 2014’, provides an overview of the Friedreich Ataxia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Friedreich Ataxia, com …
  • Huttig Building Products, Inc. (HBPI.PK) : 企業概要及びSWOT分析
    This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business. WMI's 'Huttig Building Products, Inc. (HBPI.PK) : Company Profile and SWOT Analysis' report utilizes a wide range of primary and secondary …
  • Taiwan Power Company, Ltd.(環境・エネルギー分野):企業M&A及び事業提携動向
    Summary Taiwan Power Company, Ltd. (Taiwan Power) is an integrated state-owned electric power utility. It principally generates power from fossil fuels and renewable energy sources, commercial, and residential consumers. The company also generates power from thermal sources including coal, oil, liqu …
  • Alstom – Taubaté Rail Equipments Manufacturing Plant – São Paulo:建設プロジェクト概要
    World Market Intelligence's "Alstom – Taubaté Rail Equipments Manufacturing Plant – São Paulo - Construction Project Profile" is a crucial resource for industry executives and anyone looking to access key information about the Alstom – Taubaté Rail Equipments Manufacturing Plant – São Paulo construc …
  • インフラ建設のアンゴラ市場
    Infrastructure construction market consists of a range of heavy infrastructure construction projects including, but not limited to, the construction of highways, bridges, tunnels, dams, dikes, subways, and other mass transit projects. This market includes three categories: rail infrastructure, road …
  • 航空IoTの世界市場
    Aviation IoT Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, …
  • 南アフリカの建設機械・鉱山機械市場(~2020):市場規模、動向、予測
    The report Construction and Mining Machinery Market in South Africa to 2020 - Market Size, Development, and Forecasts offers the most up-to-date industry data on the actual market situation, and future outlook for construction and mining machinery in South Africa. The research includes historic data …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DELVP501048 )"無排卵(Anovulation):治療薬開発パイプライン動向2015" (英文:Anovulation-Pipeline Insights, 2015)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。